Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines - Implications for the CNS

Journal of Neural Transmission, Supplement

Volumn , Issue 71, 2006, Pages 45-51

  Scheller, C ^a   Riederer, P ^b   Gerlach, M ^c   Koutsilieri, E ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Department of Psychiatry and Psychotherapy   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE INHIBITOR; CYTOKINE; DEATH RECEPTOR; FAS ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; NEUROPROTECTIVE AGENT; PEPTIDE CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL INVASION; CELL STIMULATION; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; BIOLOGICAL MODEL; DRUG EFFECT; DRUG INTERACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; METHODOLOGY; PHYSIOLOGY;

AMINO ACID CHLOROMETHYL KETONES; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CYTOKINES; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; MODELS, BIOLOGICAL; NEUROPROTECTIVE AGENTS; T-LYMPHOCYTES;

EID: 34248577512     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-33328-0_6     Document Type: Article

References (52)

1. Araujo DM, Cotman CW (1993) Trophic effects of interleukin-4, -7 and -8 on hippocampal neuronal cultures: potential involvement of glial-derived factors. Brain Res 600: 49-55
2. Bantel H, Bruning T, Schulze-Osthoff K (1998) Activation of caspases by death receptors. Eur Cytokine Netw 9: 681-684
3. Barker CF, Billingham RE (1977) Immunologically privileged sites. Adv Immunol 25: 1-54
4. Baud V, Karin M (2001) Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 11: 372-377
5. Bauer J, Rauschka H, Lassmann H (2001) Inflammation in the nervous system: the human perspective. Glia 36: 235-243
6. Beck RD Jr, King MA, Ha GK, Cushman JD, Huang Z, Petitto JM (2005a) IL-2 deficiency results in altered septal and hippocampal cytoarchitecture: relation to development and neurotrophins. J Neuroimmunol 160: 146-153
7. Beck RD Jr, Wasserfall C, Ha GK, Cushman JD, Huang Z, Atkinson MA, Petitto JM (2005b) Changes in hippocampal IL-15, related cytokines, and neurogenesis in IL-2 deficient mice. Brain Res 1041: 223-230
8. Beloosesky Y, Salman H, Bergman M, Bessler H, Djaldetti M (2002) Cytokine levels and phagocytic activity in patients with Alzheimer's disease. Gerontology 48: 128-132
9. Bilsland J, Roy S, Xanthoudakis S, Nicholson DW, Han Y, Grimm E, Hefti F, Harper SJ (2002) Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J Neurosci 22: 2637-2649
10. Brodie C, Goldreich N, Haiman T, Kazimirsky G (1998) Functional IL-4 receptors on mouse astrocytes: IL-4 inhibits astrocyte activation and induces NGF secretion. J Neuroimmunol 81: 20-30
11. Chuang D, Power SE, Dunbar PR, Hill AG (2005) Central nervous system interleukin-8 production following neck of femur fracture. ANZ J Surg 75: 813-816
12. Chun TW, Fauci AS (1999) Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci USA 96: 10958-10961
13. Delgado AV, McManus AT, Chambers JP (2003) Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37: 355-361
14. Dragunow M, MacGibbon GA, Lawlor P, Butterworth N, Connor B, Henderson C, Walton M, Woodgate A, Hughes P, Faull RL (1997) Apoptosis, neurotrophic factors and neurodegeneration. Rev Neurosci 8: 223-265
15. Eberhardt O, Coelln RV, Kugler S, Lindenau J, Rathke-Hartlieb S, Gerhardt E, Haid S, Isenmann S, Gravel C, Srinivasan A, Bahr M, Weller M, Dichgans J, Schulz JB (2000) Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. J Neurosci 20: 9126-9134
16. Ehrlich LC, Hu S, Sheng WS, Sutton RL, Rockswold GL, Peterson PK, Chao CC (1998) Cytokine regulation of human microglial cell IL-8 production. J Immunol 160: 1944-1948
17. Fiskum G, Starkov A, Polster BM, Chinopoulos C (2003) Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease. Ann NY Acad Sci 991: 111-119
18. Flugel A, Bradl M (2001) New tools to trace populations of inflammatory cells in the CNS. Glia 36: 125-136
19. Flugel A, Schwaiger FW, Neumann H, Medana I, Willem M, Wekerle H, Kreutzberg GW, Graeber MB (2000) Neuronal FasL induces cell death of encephalitogenic T lymphocytes. Brain Pathol 10: 353-364
20. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD (1996) Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184: 1737-1745
21. Frigerio S, Silei V, Ciusani E, Massa G, Lauro GM, Salmaggi A (2000) Modulation of fas-ligand (Fas-L) on human microglial cells: an in vitro study. J Neuroimmunol 105: 109-114
22. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ (2002) Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 196: 851-857
23. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72: 847-855
24. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890
25. Hulshof S, Montagne L, De Groot CJ, Van Der Valk P (2002) Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions. Glia 38: 24-35
26. Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 176: 1355-1364
27. Magnus T, Chan A, Savill J, Toyka KV, Gold R (2002) Phagocytotic removal of apoptotic, inflammatory lymphocytes in the central nervous system by microglia and its functional implications. J Neuroimmunol 130: 1-9
28. Mandel S, Grünblatt E, Riederer P, Gerlach M, Levites Y, Youdim MBH (2003) Neuroprotective strategies in Parkinson's disease. An update on progress. CNS Drugs 17: 729-762
29. Mandel S, Weinreb O, Amit T, Youdim MB (2005) Mechanism of neuroprotective action of the anti-Parkinson drug rasagiline and its derivatives. Brain Res Brain Res Rev 48: 379-387
30. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500-14505
31. Nagatsu T, Mogi M, Ichinose H, Togari A (2000) Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm [Suppl]: 277-290
32. Neumann H, Wekerle H (1998) Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 57: 1-9
33. Nguyen KB, Pender MP (1998) Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis. Acta Neuropathol (Berl) 95: 40-46
34. Okuda Y, Sakoda S, Fujimura H, Yanagihara T (2000) The effect of apoptosis inhibitors on experimental autoimmune encephalomyelitis: apoptosis as a regulatory factor. Biochem Biophys Res Commun 267: 826-830
35. Pender MP, Rist MJ (2001) Apoptosis of inflammatory cells in immune control of the nervous system: role of glia. Glia 36: 137-144
36. Plata-Salaman CR, Borkoski JP (1993) Interleukin-8 modulates feeding by direct action in the central nervous system. Am J Physiol 265: 877-882
37. Pouly S, Antel JP, Ladiwala U, Nalbantoglu J, Becher B (2000) Mechanisms of tissue injury in multiple sclerosis: opportunities for neuroprotective therapy. J Neural Transm [Suppl]: 193-203
38. Puma C, Danik M, Quirion R, Ramon F, Williams S (2001) The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78: 960-971
39. Reed JC (1999) Dysregulation of apoptosis in cancer. J Clin Oncol 17: 2941-2953
40. Rescigno M, Piguet V, Valzasina B, Lens S, Zubler R, French L, Kindler V, Tschopp J, Ricciardi-Castagnoli P (2000) Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1 beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J Exp Med 192: 1661-1668
41. Rideout HJ, Stefanis L (2001) Caspase inhibition: a potential therapeutic strategy in neurological diseases. Histol Histopathol 16: 895-908
42. Scheller C, Jassoy C (2001) Syncytium formation amplifies apoptotic signals: a new view on apoptosis in HIV infection in vitro. Virology 282: 48-55
43. Scheller C, Knoferle J, Ullrich A, Prottengeier J, Racek T, Sopper S, Jassoy C, Rethwilm A, Koutsilieri E (2005) Caspase inhibition in apoptotic T cells triggers necrotic cell death depending on the cell type and the proapoptotic stimulus. J Cell Biochem: In press
44. Scheller C, Sopper S, Chen P, Flory E, Koutsilieri E, Racek T, Ludwig S, ter Meulen V, Jassoy C (2002a) Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95. J Biol Chem 277: 15459-15464
45. Scheller C, Sopper S, Ehrhardt C, Flory E, Chen P, Koutsilieri E, Ludwig S, ter Meulen V, Jassoy C (2002b) Caspase inhibitors induce a switch from apoptotic to proinflammatory signaling in CD95-stimulated T lymphocytes. Eur J Immunol 32: 2471-2480
46. Scheller C, Sopper S, Koutsilieri E, Ludwig S, Ter Meulen V, Jassoy C (2003) Caspase inhibitors as a supplement in immune activation therapies to achieve eradication of HIV in its latent reservoirs. Ann NY Acad Sci 1010: 209-212
47. Schroeter M, Jander S (2005) T-cell cytokines in injury-induced neural damage and repair. NeuroMolecular Medicine: In press
48. Vass K, Lassmann H (1990) Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am J Pathol 137: 789-800
49. Wellington CL, Hayden MR (2000) Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin Genet 57: 1-10
50. Wirjatijasa F, Dehghani F, Blaheta RA, Korf HW, Hailer NP (2002) Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells. J Neurosci Res 68: 579-587
51. Wekerle H, Linington C, Lassmann H, Meyermann R (1986) Cellular immune reactivity within the CNS. Trends Neurosci 9: 271-277
52. Xia M, Qin S, McNamara M, Mackay C, Hyman BT (1997) Interleukin-8 receptor B immunoreactivity in brain and neuritic plaques of Alzheimer's disease. Am J Pathol 150: 1267-1274